- Home
- XNCR vs VSEC Comparison
XNCR vs VSEC Comparison
Compare XNCR & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | VSEC |
|---|---|---|
| Founded | 1997 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 6.8B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | XNCR | VSEC |
|---|---|---|
| Price | $25.28 | $209.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $22.33 | ★ $226.29 |
| AVG Volume (30 Days) | ★ 1.3M | 289.7K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.25% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ 1.94 |
| Revenue | $125,576,000.00 | ★ $760,113,000.00 |
| Revenue This Year | N/A | $32.16 |
| Revenue Next Year | $4.80 | $21.36 |
| P/E Ratio | ★ N/A | $105.11 |
| Revenue Growth | ★ 13.65 | 9.88 |
| 52 Week Low | $8.29 | $154.74 |
| 52 Week High | $30.61 | $247.85 |
Technical Indicators
Market Signals| Indicator | XNCR | VSEC |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 48.05 |
| Support Level | $11.20 | $163.30 |
| Resistance Level | $30.61 | $212.58 |
| Average True Range (ATR) | 1.68 | 9.10 |
| MACD | -0.52 | -2.59 |
| Stochastic Oscillator | 6.01 | 41.83 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.